Aging and Disease,
Год журнала:
2025,
Номер
unknown, С. 0 - 0
Опубликована: Янв. 1, 2025
As
the
resident
macrophages
of
brain,
microglia
are
crucial
immune
cells
specific
to
central
nervous
system
(CNS).
They
constantly
surveil
their
surroundings
and
trigger
immunological
reactions,
playing
a
key
role
in
various
neurodegenerative
diseases
(ND).
illnesses
progress,
exhibit
multiple
phenotypes.
Traditionally,
have
been
classified
into
two
main
phenotypes
upon
activation:
pro-inflammatory
M1
polarization
anti-inflammatory
M2
polarization.
However,
this
classification
is
now
considered
overly
simplistic,
as
it
unable
fully
convey
intricacy
diversity
inflammatory
response.
Immune
regulatory
factors,
such
chemokines
secreted
by
microglia,
essential
for
modulating
brain
development,
maintaining
neural
milieu,
orchestrating
responses
injury,
along
with
subsequent
repair
processes.
recent
years,
significance
metabolic
reprogramming
both
physiological
microglial
activity
ND
has
also
become
increasingly
recognized.
Upon
activation-triggered
infection,
or
ND-microglia
typically
modify
processes
transitioning
from
oxidative
phosphorylation
(OXPHOS)
glycolysis.
This
shift
facilitates
rapid
energy
production
but
may
enhance
responses.
review
seeks
summarize
function
involvement
ND.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(7), С. 6328 - 6328
Опубликована: Март 28, 2023
Neuroinflammation
is
a
critical
factor
in
developing
and
progressing
numerous
brain
diseases,
including
neurodegenerative
diseases.
Chronic
or
excessive
neuroinflammation
can
lead
to
neurotoxicity,
causing
damage
contributing
the
onset
progression
of
various
Therefore,
understanding
mechanisms
strategies
control
them
crucial
for
treating
Studies
have
shown
that
plays
vital
role
such
as
Alzheimer's
(AD)
Parkinson's
(PD),
stroke.
Additionally,
effects
PM
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(22), С. 16288 - 16288
Опубликована: Ноя. 14, 2023
The
blood-brain
barrier
(BBB)
is
a
unique
and
selective
feature
of
the
central
nervous
system's
vasculature.
BBB
dysfunction
has
been
observed
as
an
early
sign
Alzheimer's
Disease
(AD)
before
onset
dementia
or
neurodegeneration.
intricate
relationship
between
pathogenesis
AD,
especially
in
context
neurovascular
coupling
overlap
pathophysiology
neurodegenerative
cerebrovascular
diseases,
underscores
urgency
to
understand
BBB's
role
more
deeply.
Preserving
restoring
function
emerges
potentially
promising
strategy
for
mitigating
progression
severity
AD.
Molecular
genetic
changes,
such
isoform
ε4
apolipoprotein
E
(ApoEε4),
significant
risk
factor
promoter
dysfunction,
have
shown
mediate
disruption.
Additionally,
receptors
transporters
like
low-density
lipoprotein
receptor-related
protein
1
(LRP1),
P-glycoprotein
(P-gp),
receptor
advanced
glycation
end
products
(RAGEs)
implicated
AD's
pathogenesis.
In
this
comprehensive
review,
we
endeavor
shed
light
on
pathogenic
therapeutic
connections
AD
BBB.
We
also
delve
into
latest
developments
pioneering
strategies
targeting
interventions,
addressing
its
potential
carrier.
By
providing
integrative
perspective,
anticipate
paving
way
future
research
treatments
focused
exploiting
therapy.
Biomedicine & Pharmacotherapy,
Год журнала:
2023,
Номер
164, С. 114312 - 114312
Опубликована: Май 19, 2023
Neurodegenerative
diseases,
such
as
Alzheimer's
disease
(AD),
are
characterized
by
massive
loss
of
specific
neurons.
It
is
a
progressive
disabling,
severe
and
fatal
complex
disease.
Due
to
its
pathogenesis
limitations
clinical
treatment
strategies,
it
poses
serious
medical
challenge
burden
worldwide.
The
AD
not
clear,
potential
biological
mechanisms
include
aggregation
soluble
amyloid
form
insoluble
plaques,
abnormal
phosphorylation
tau
protein
formation
intracellular
neurofibrillary
tangles
(NFT),
neuroinflammation,
ferroptosis,
oxidative
stress
metal
ion
disorders.
Among
them,
ferroptosis
newly
discovered
programmed
cell
death
induced
iron-dependent
lipid
peroxidation
reactive
oxygen
species.
Recent
studies
have
shown
that
closely
related
AD,
but
the
mechanism
remains
unclear.
may
be
iron
metabolism,
amino
acid
metabolism
affecting
accumulation
ions.
Some
chelating
agents
(deferoxamine,
deferiprone),
chloroiodohydroxyquine
derivatives,
antioxidants
(vitamin
E,
lipoic
acid,
selenium),
derivatives
Fer-1,
tet,
etc.
been
in
animal
effective
exert
neuroprotective
effects.
This
review
summarizes
regulation
natural
plant
products
on
order
provide
reference
information
for
future
research
development
inhibitors.
Behavioral and Brain Functions,
Год журнала:
2025,
Номер
21(1)
Опубликована: Янв. 8, 2025
Alzheimer's
disease
(AD)
is
a
prevalent
and
progressive
neurodegenerative
disorder
that
the
leading
cause
of
dementia.
The
underlying
mechanisms
AD
have
not
yet
been
completely
explored.
Neuroinflammation,
an
inflammatory
response
mediated
by
certain
mediators,
has
exhibited
to
play
crucial
role
in
pathogenesis
AD.
Additionally,
disruption
gut
microbiota
found
be
associated
with
AD,
fecal
transplantation
(FMT)
emerged
as
potential
therapeutic
approach.
However,
precise
mechanism
FMT
treatment
remains
elusive.
In
this
study,
was
performed
transplanting
from
healthy
wild-type
mice
into
APP/PS1
(APPswe,
PSEN1dE9)
assess
effectiveness
mitigating
AD-associated
inflammation
reveal
its
action.
results
demonstrated
improved
cognitive
function
reduced
expression
levels
factors
regulating
TLR4/MyD88/NF-κB
signaling
pathway
mice,
which
accompanied
restoration
microbial
dysbiosis.
These
findings
suggest
ameliorate
symptoms
delay
progression
mice.
Alzheimer s Research & Therapy,
Год журнала:
2023,
Номер
15(1)
Опубликована: Окт. 2, 2023
Abstract
Background
Chronic
stress
and
depression
are
potential
risk
factors
for
mild
cognitive
impairment
dementia,
including
Alzheimer
disease.
The
aim
was
to
investigate
whether
any
such
is
additive.
Methods
Cohort
study
1
362
548
people
(665
997
women,
696
551
men)
with
records
in
the
Region
Stockholm
administrative
healthcare
database
(VAL).
Exposure
a
recorded
ICD-10
diagnosis
of
chronic
stress,
depression,
or
both,
2012
2013.
Outcome
disease,
other
from
2014
through
2022.
Odds
ratios
99%
confidence
intervals
(CI)
adjusted
age,
sex,
neighborhood
socioeconomic
status,
diabetes,
cardiovascular
disorders
were
calculated.
Results
During
exposure
period,
4
346
patients
diagnosed
40
101
898
both.
average
age
at
baseline
around
years
all
groups.
In
fully
model,
odds
ratio
disease
2.45
(99%
CI
1.22–4.91)
2.32
1.85–2.90)
4.00
1.67–9.58)
depression.
1.87
1.20–2.91)
2.85
2.53–3.22)
3.87
2.39–6.27)
When
dementia
analyzed,
significant
only
2.39
1.92–2.96).
Conclusions
Documented
increased
same
seen
novel
finding
additive
effect
on
MCI
AD.
Frontiers in Nutrition,
Год журнала:
2023,
Номер
10
Опубликована: Июль 26, 2023
Apigenin
is
a
bioflavonoid
compound
that
widely
present
in
dietary
plant
foods
and
possesses
biological
activities
protect
against
immune,
cardiovascular,
neurodegenerative
diseases
cancer.
Therefore,
apigenin
used
food
medicine,
increasing
attention
has
been
drawn
to
developing
new
delivery
systems
for
apigenin.
This
review
highlights
the
effects,
metabolism,
stability,
bioactivity
of
In
addition,
we
summarized
advancements
apigenin,
which
provides
some
references
its
widespread
use
medicine.
Better
stability
may
enhance
digestion
absorption
provide
health
benefits.
Constructing
(such
as
emulsions,
nanostructured
lipid
carriers,
hydrogels,
liposomes)
an
effective
strategy
improve
bioavailability,
but
more
animal
cell
experiments
are
needed
verify
these
findings.
Developing
commercialization
still
challenging,
further
research
promote
their
in-depth
development
utilization.
Journal of Materials Chemistry B,
Год журнала:
2023,
Номер
11(36), С. 8605 - 8621
Опубликована: Янв. 1, 2023
Alzheimer's
disease
(AD)
is
a
neurodegenerative
that
causes
memory
and
cognitive
dysfunction
reduces
person's
decision-making
reasoning
functions.
AD
the
leading
cause
of
dementia
in
elderly.
Patients
with
have
increased
expression
pro-inflammatory
cytokines
nervous
system,
sustained
inflammatory
response
impairs
neuronal
function.
Meanwhile,
long-term
use
anti-inflammatory
drugs
can
reduce
incidence
to
some
extent.
This
confirms
anti-neuroinflammation
may
be
an
effective
treatment
for
AD.
Gold
nanoparticles
(AuNPs)
are
emerging
nanomaterial
promising
physicochemical
properties,
antioxidant.
AuNPs
neuroinflammation
by
inducing
macrophage
polarization
toward
M2
phenotype,
reducing
cytokine
expression,
blocking
leukocyte
adhesion,
decreasing
oxidative
stress.
Therefore,
gradually
attracting
interest
scholars
used
treating
diseases
drug
delivery.
Herein,
we
explored
role
mechanism
The
topic
worth
exploring
future,
not
only
help
solve
global
public
health
problem
but
also
provide
reference
other
neuroinflammatory
diseases.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(6), С. 5383 - 5383
Опубликована: Март 11, 2023
Alzheimer’s
disease
(AD)
is
an
incurable,
progressive
neurodegenerative
disorder.
AD
a
complex
and
multifactorial
that
responsible
for
60–80%
of
dementia
cases.
Aging,
genetic
factors,
epigenetic
changes
are
the
main
risk
factors
AD.
Two
aggregation-prone
proteins
play
decisive
role
in
pathogenesis:
β-amyloid
(Aβ)
hyperphosphorylated
tau
(pTau).
Both
them
form
deposits
diffusible
toxic
aggregates
brain.
These
biomarkers
Different
hypotheses
have
tried
to
explain
pathogenesis
served
as
platforms
drug
research.
Experiments
demonstrated
both
Aβ
pTau
might
start
processes
necessary
cognitive
decline.
The
two
pathologies
act
synergy.
Inhibition
formation
has
been
old
target.
Recently,
successful
clearance
by
monoclonal
antibodies
raised
new
hopes
treatments
if
detected
at
early
stages.
More
recently,
novel
targets,
e.g.,
improvements
amyloid
from
brain,
application
small
heat
shock
(Hsps),
modulation
chronic
neuroinflammation
different
receptor
ligands,
microglial
phagocytosis,
increase
myelination
revealed
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(3), С. 1914 - 1914
Опубликована: Фев. 5, 2024
Alzheimer’s
disease
(AD)
is
a
progressive
neurodegenerative
disorder
that
characterized
by
several
pathological
hallmarks,
including
the
deposition
of
amyloid-β
(Aβ)
plaques,
neurofibrillary
tangles,
blood–brain
barrier
(BBB)
dysfunction,
increased
oxidative
stress,
and
neuroinflammation.
Current
treatment
options
include
monoclonal
antibody
drugs,
acetylcholinesterase,
n-methyl-d-aspartate
(NMDA)
antagonists.
Although
those
treatments
provide
some
improvements
in
patients’
quality
life,
they
fail
to
prevent
or
cure
AD.
research
aims
identify
novel
targets
tools
for
AD
prevention
modification.
In
this
context,
studies
showed
beneficial
effect
Mediterranean
diet
One
integral
component
olive
oil
extra-virgin
(EVOO),
which
high
phenolic
compounds.
EVOO
other
olive-related
compounds
have
been
shown
reduce
risk
developing
mild
cognitive
impairment
(MCI)
review,
we
discuss
mechanisms
exert
neuroprotective
effects,
modulation
pathologies
promotion
health.
Findings
indicate
its
constituents
influence
key
processes
AD,
such
as
Aβ
aggregation,
tau
phosphorylation,
neuroinflammation,
while
also
enhancing
BBB
integrity
reducing
stress.
The
human
cited
reveal
consistent
trend
where
consumption
associated
with
benefits
decreased
related
dementias.
conclusion,
hold
promising
potential
representing
significant
shift
towards
more
effective
strategies
against
complex
disorder.